Report Highlights
-
The overall U.S. imaging equipment and auxiliary products market is estimated to be $7.9 billion in 2004 and is expected to increase at a 5.7% AAGR (average annual growth rate) to reach $10.4 billion by 2009.
-
The fastest-growing category of the imaging market consists of computer systems used as adjuncts for disease detection and results archiving. These will constitute 21% of the market in 2009, up from 14% in 2004.
-
Systems whose sales are expected to grow most rapidly include computed radiography and direct digital radiography units, 64-slice CT scanners, 3.0-Tesla MRI scanners, multimodal SPECT/CT and PET/CT scanners and hand-carried ultrasound units.
-
Products such as conventional radiography and fluoroscopy units, singleslice CT scanners and gamma cameras will show low or negative growth.
INTRODUCTION
Medical imaging is robust, technically intensive and changing. In the century following Wilhelm Roentgen's accidental discovery of the imaging capability of Xrays, additional methods of imaging body tissues such as ultrasound, nuclear medicine, computed tomography and magnetic resonance imaging have emerged. Today, imaging devices reveal every organ and lay bare every disease in more detail and with greater accuracy.
These devices even analyze the images they produce. They identify malignancies, count plaque deposits in arteries, measure bone loss and calculate the heart's pumping capacity. They also assist surgeons, tracking the positions of their instruments in real time and letting them know what their scalpels are about to cut into.
This BCC report shows how a global industry of competitive and visionary firms, ranging from giant market leaders to ambitious startups, has drawn together scientific advances from many fields to deliver a remarkable series of product innovations. It outlines new opportunities in medical imaging and forecasts markets by product category, application and geographical area through 2009. In addition to medical imaging equipment, markets for auxiliary products are reviewed. Emerging imaging methods that appear promising but have not yet had a major impact on the marketplace are identified.
SCOPE OF STUDY
The report contains:
- A focus on the modalities generally considered part of the medical imaging industry, such as:
- X-ray, including radiography and fluoroscopy
- computed tomography
- magnetic resonance imaging
- ultrasound
- nuclear medicine, including both single-photon emission studies and positron emission tomography - A review of some of the newer imaging modalities
- Analysis of the industry's structure, regulatory environment and salient technological developments in each area
- Market forecasts for each type of product and application, and for geographical areas of the world through 2009
- Profiles of many of the leading companies in the industry
METHODOLOGY
We employed statistical forecasting techniques along with considering developments in technology and other factors affecting demand for equipment. These factors are discussed in each forecast section of the report. Other published forecasts were considered and critically assessed. All projections are in 2004 constant dollars.
INFORMATION SOURCES
To research this report, we reviewed data published by government agencies and industry and professional associations; motions filed in lawsuits; vendors' annual reports, SEC filings, presentations, regulatory submissions, press releases, and product literature; healthcare providers' annual reports, SEC filings, web sites, and published purchasing plans; and secondary information such as articles in scientific, medical, and industry journals. Information and analysis was also obtained through direct discussion or correspondence with manufacturers, healthcare providers, government agencies, and industry and professional associations.
ANALYST CREDENTIALS
Masha Zager is a writer specializing in and technology. Trained as an economist, she has written about information technology, telecommunications, call center technology, energy markets, securities markets, municipal finance, and a wide variety of other subjects. She was the author of BCC Report B-140R, Medical Imaging, the precursor to this report.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Healthcare Fraud Detection Market
This report provides a brief general outlook of the global healthcare fraud detection market. It includes global revenue ($ million) for base year data of 2024, estimated data of 2025, and forecasts through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Global Orthopedic Surgical Robots Market
The global market for orthopedic surgical robots was valued at $2.7 billion in 2025 and is expected to reach $4.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2030.
Chronic Kidney Disease: Global Markets and Technologies
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
State of the Life Sciences Industry - 2026 First Quarter Review
Explore BCC Research’s Q1 2026 review of the life sciences industry, covering market trends, innovation, sector performance, and growth outlook.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Top Trending Reports
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Glass Fiber: Global Markets
The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.
2025 Chemical Research Review
BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.
Report Highlights
-
Sales of imaging equipment, for which the U.S. market is projected to reach $6.1 billion in 2002, are expected to grow at a 3.4% AAGR, reaching $7.2 billion (in 2002 dollars) by 2007.
-
The imaging products whose sales are expected to grow most rapidly include digital radiography units, multislice CT scanners, open and ultra- high-field MRI, multimodal CT/PET scanners, and ultrasound, especially portable ultrasound units.
-
The clinical use of PET (positron emission tomography) and the installed base of dedicated PET scanners will also increase dramatically over the forecast period, although the sales expansion of the last few years is expected to moderate.
-
The fastest-growing category of the imaging market consists of computer systems that are used as adjuncts to imaging equipment.
Report Highlights
-
The U.S. diagnostic imaging is a growing multibillion market. The total market is growing at an average annual growth rate (AAGR) of 5.9% through 2004. Valued at just over $4 billion in 1999, diagnostic imaging will generate nearly $5.4 billion by the 2004.
-
X-ray systems dominate the market in terms of growth and revenue, growing at an AAGR of 7.8% and garnering a 47.7% share. Digital systems, a relatively small fraction of the X-ray systems market, are nonetheless on pace to eventually replace older equipment. These systems alone are experiencing market growth of nearly 23% per year on average. By 2004, X-ray systems will account for 52.1% of the market for diagnostic imaging equipment.
-
CT, Ultrasound, and nuclear medicine systems, while experiencing sales growth, are not expected to keep pace. Together, CT and Ultrasound systems will grow at an AAGR of 4.1% through the period, while systems for nuclear medicine will grow at an average annual rate of only 3.4%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More